Recursion Pharmaceuticals Inc (RXRX) Stock Analysis

Recursion Pharmaceuticals Inc (RXRX) is a publicly traded company in the HEALTHCARE sector. It trades at $3.79, carries a market capitalization of $1.91B. This page summarizes the public market data, fundamentals, and frequently asked questions for RXRX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Recursion Pharmaceuticals Inc currently has a Neutral sentiment score of -0.12.

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. (RXRX) is an innovative clinical-stage biotechnology company headquartered in Salt Lake City, Utah, that is revolutionizing drug discovery by integrating advanced technologies across biology, chemistry, and data science. Utilizing a proprietary platform that fuses high-throughput automation with deep learning capabilities, Recursion endeavors to decipher intricate biological systems, aiming to identify and develop transformative therapies for a wide range of di...

GNG Research Analysis

GNG Research scores Recursion Pharmaceuticals Inc (RXRX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RXRX.

Frequently Asked Questions

Does RXRX pay dividends?

Recursion Pharmaceuticals Inc (RXRX) does not currently pay a regular dividend.

What is RXRX's market cap?

Recursion Pharmaceuticals Inc (RXRX) has a market capitalization of $1.91B with a current stock price of $3.79.